News
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
Regulatory News:
The shareholders of Median Technologies (ALMDT:PA) are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Tuesday June
PhosAgro PJSC: PhosAgro Has Been Notified of Change in Vladimir Litvinenko’s Stake in the Company’s Share Capital
RUBIS: Results from the capital increase reserved for Group employees
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Diamondx Selected for Internet of Things Semiconductor Test
Cohu, Inc. (NASDAQ: COHU), a global leader in back-end semiconductor equipment and services, today announced a leading U.S. semiconductor manufacturer has selected the Diamondx platform for testing
AIG Releases Second Environmental, Social and Governance (ESG) Report
American International Group, Inc. (NYSE: AIG) today released its 2021 Environmental, Social and Governance (ESG) Report.
The 2021 ESG Report builds upon AIG’s inaugural ESG Report published last
Braze for Success Guides Leading Brands to Long-Term Growth With Best-in-Class Support, Education, and Community
Braze (Nasdaq: BRZE), the comprehensive customer engagement platform that powers interactions between consumers and the brands they love, today announced Braze for Success, a series of new
DGAP-News: asknet Solutions AG: Extraordinary General Meeting approves both agenda items
Guidewire’s Insurtech Vanguards Program Reaches Growth Milestone, Connecting 25 New P&C Industry Insurtechs with Insurers
Guidewire (NYSE: GWRE) today announced that its Insurtech Vanguards program, an initiative providing a channel for connecting P&C insurers with technology innovators, has reached a significant
Innoviva to Acquire Entasis Therapeutics
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and Entasis Therapeutics Holdings
DGAP-News: Basler AG: Shareholders of Basler AG approve agenda items of today’s Annual General Meeting with a large majority
NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service
NICE (Nasdaq: NICE) today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on
Advance Auto Parts Announces Innovative, First to Market 12-Volt DieHard Battery Designed Specifically for Hybrid and Electric Vehicles
Advance Auto Parts (NYSE: AAP), a leading automotive aftermarket parts retailer, today announced the introduction of DieHard® EV with xEV by Clarios, becoming the first auto parts retailer to sell
EVO Payments Acquires North49 to Deliver B2B Integrated Payments for Sage Users
EVO Payments, Inc. (NASDAQ:EVOP) ("EVO" or "the Company"), a leading global provider of payment technology integrations and acquiring solutions, today announced it has acquired North49 Business
ICON Named Business & Finance Company of the Year and One of Forbes’ Best Employers for Diversity
ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, has been
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Tumor Myeloid-Directed Therapies Summit Annual Meeting
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
DGAP-News: VERIANOS SE publishes consolidated figures for the financial year 2021
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc